Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents with Narcolepsy

Study Title

Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy

Teva Identifier

C10953/1100 | 2012-005510-20

ClinicalTrials.gov Identifier

NCT01624480

Study Status

Completed

Trial Condition(s)

Narcolepsy

Interventions

Drug: Armodafinil

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

6 Years to 17 Years

Trial Duration

07/01/2012 - 12/01/2015

Phase

Phase 1

Study Type

Interventional